Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Lemont. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Lemont at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This study is a Phase IIIb/IV, multicenter, randomized, two-arm, open-label 100-week study to investigate the efficacy, safety, and durability of intravitreal 6-mg faricimab administered at up to 24-week intervals in patients with neovascular age-related macular degeneration (nAMD) that are treatment-naïve in the study eye.
Sponsor: Hoffmann-La Roche
Check if you qualify for this macular degeneration clinical trial in Lemont, IL
If you're searching for macular degeneration treatment options in Lemont, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lemont research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.